Nxera Pharma Co., Ltd. (SOLTF)

Nxera Pharma Revenue

Nxera Pharma had revenue of 8.45B JPY in the quarter ending June 30, 2025, with 4.21% growth. This brings the company's revenue in the last twelve months to 31.21B, up 33.71% year-over-year. In the year 2024, Nxera Pharma had annual revenue of 28.84B with 125.87% growth.

• Revenue (ttm): 31.21B JPY
• Revenue Growth: +33.71%
• P/S Ratio: 2.59
• Revenue / Employee: 83.45M JPY
• Employees: 374
• Market Cap: 560.66M USD

Revenue Chart

* This company reports financials in JPY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	28.84B	16.07B	125.87%
Dec 31, 2023	12.77B	-2.80B	-18.00%
Dec 31, 2022	15.57B	-2.14B	-12.10%
Dec 31, 2021	17.71B	8.87B	100.32%
Dec 31, 2020	8.84B	-884.00M	-9.09%